Encinitas, CA, United States of America

Nicholas A Boyle


Average Co-Inventor Count = 12.0

ph-index = 3

Forward Citations = 278(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Nicholas A Boyle

Introduction

Nicholas A Boyle is an accomplished inventor based in Encinitas, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleotide mimics and their prodrugs. With a total of three patents to his name, Boyle's work has the potential to impact the treatment of various viral and microbial infections, as well as cancer.

Latest Patents

Boyle's latest patents focus on nucleoside diphosphate mimics and nucleoside triphosphate mimics. These inventions include diphosphate or triphosphate moiety mimics, which may also feature sugar-modifications and/or base-modifications. The nucleotide mimics are presented in forms such as pharmaceutically acceptable salts, prodrugs, or pharmaceutical formulations. They are designed to serve as antiviral, antimicrobial, and anticancer agents. Furthermore, his inventions provide methods for treating viral infections, microbial infections, and proliferative disorders. The patents also encompass pharmaceutical compositions that may include these compounds in combination with other active agents.

Career Highlights

Throughout his career, Nicholas A Boyle has worked with notable companies, including Biota Scientific Management Pty Ltd and Biota, Inc. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and the development of innovative treatments.

Collaborations

Boyle has collaborated with several professionals in his field, including Phillip Dan Cook and Guangyi Wang. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Nicholas A Boyle is a prominent inventor whose work in nucleotide mimics and their prodrugs holds promise for advancing medical treatments. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…